SynthesisBMC health services research2007
HEE-GER: a systematic review of German economic evaluations of health care published 1990-2004.
Synthesis in BMC health services research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007-2019) Conducted in South Korea.Applied health economics and health policy · 2022Pooled it
- Pooled it
- A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries.BMC public health · 2012Pooled it
- Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013.Frontiers in public health · 2018Article
- Methodological reviews of economic evaluations in health care: what do they target?The European journal of health economics : HEPAC : health economics in prevention and care · 2014Article
- A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.Annals of the New York Academy of Sciences · 2014Review
- Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature.Cost effectiveness and resource allocation : C/E · 2014Review
- Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.BMC health services research · 2012Article
- The opportunities for and obstacles against prevention: the example of Germany in the areas of tobacco and alcohol.BMC public health · 2010Article
- Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective.Cost effectiveness and resource allocation : C/E · 2009Article
- The economics of primary prevention of cardiovascular disease - a systematic review of economic evaluations.Cost effectiveness and resource allocation : C/E · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStudies published in non-English languages are systematically missing in systematic reviews of growth and quality of economic evaluations of health care. The aims of this study were: to characterize German evaluations, published in English or German-language, in terms of various key parameters; to investigate methods to derive quality-of-life weights in cost-utility studies; and to examine changes in study characteristics over the years.
methodsWe conducted a country-specific systematic review of the German and English-language literature of German economic evaluations (assessment of or application to the German health care system) published 1990-2004. Generic and specialized health economic databases were searched. Two independent reviewers verified fulfillment of inclusion criteria and extracted study characteristics.
resultsThe fulltexts of 730 articles were reviewed of which 283 fulfilled all entry criteria. 32% of included studies were published in German-language. 51% of studies evaluated pharmaceuticals and 63% were cost-effectiveness analyses. Economic appraisals concentrate on few disease categories and important health areas are strongly underrepresented. Declaration of sponsorship was associated with article language (49% English articles vs. 29% German articles, p < 0.001). The methodology used to obtain quality-of-life weights in published cost-utility studies was very diverse, poorly reported and most studies did not use German patients' or community health state evaluations.
conclusionMany of the German-language evaluations included in our study are likely to be missing in international reviews and may be systematically different from English-language reviews from Germany. Lack of transparency and adherence to recommended reporting practices constitute a serious problem in German economic evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.